English | 繁體

Search in the results

UM

Browse/Search Results:  1-9 of 9 Help

Selected(0)Clear Items/Page:    Sort:
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer Journal article
Wei-Bang Yu, Yu-Chi Chen,, Can-Yu Huang, Zi-Han Ye, Wei Shi, Hong Zhu, Jia-Jie Shi, Jun Chen, Jin-Jian Lu. CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer[J]. Frontiers of Medicine, 2022, 17(1), 105-118.
Authors:  Wei-Bang Yu;  Yu-Chi Chen,;  Can-Yu Huang;  Zi-Han Ye;  Wei Shi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.9/5.4 | Submit date：2023/01/30
Adcp  Anti-cd47 Antibody  Combination Strategy  Egfr  Osimertinib  
Anticancer Effects of Ginsenoside Rh2: A Systematic Review Journal article
He, Xin Ling, Xu, Xiao Huang, Shi, Jia Jie, Huang, Mingqing, Wang, Yitao, Chen, Xiuping, Lu, Jin Jian. Anticancer Effects of Ginsenoside Rh2: A Systematic Review[J]. Current Molecular Pharmacology, 2022, 15(1), 179-189.
Authors:  He, Xin Ling;  Xu, Xiao Huang;  Shi, Jia Jie;  Huang, Mingqing;  Wang, Yitao; et al.
Favorite | TC[WOS]:7 TC[Scopus]:7  IF:2.4/2.8 | Submit date：2022/02/21
Cancer  Cytotoxicity  Ginseng  Ginsenoside Rh2  Mechanism  Natural Compound  
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective Journal article
Chen, Yu Chi, Shi, Wei, Shi, Jia Jie, Lu, Jin Jian. Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective[J]. Journal of Cancer Research and Clinical Oncology, 2022, 148(1), 1-14.
Authors:  Chen, Yu Chi;  Shi, Wei;  Shi, Jia Jie;  Lu, Jin Jian
Favorite | TC[WOS]:27 TC[Scopus]:27  IF:2.7/3.1 | Submit date：2022/02/21
Anemia  Cd47/sirpα  Immunotherapy  Macrophages  Phagocytosis Checkpoint  
The development of small-molecule inhibitors targeting CD47 Journal article
Yu,Wei Bang, Ye,Zi Han, Chen,Xiuping, Shi,Jia Jie, Lu,Jin Jian. The development of small-molecule inhibitors targeting CD47[J]. Drug Discovery Today, 2021, 26(2), 561-568.
Authors:  Yu,Wei Bang;  Ye,Zi Han;  Chen,Xiuping;  Shi,Jia Jie;  Lu,Jin Jian
Favorite | TC[WOS]:47 TC[Scopus]:48  IF:6.5/7.3 | Submit date：2021/03/01
Bioactive platycodins from Platycodonis Radix: Phytochemistry, pharmacological activities, toxicology and pharmacokinetics Journal article
Zhang,Le Le, Huang,Mu Yang, Yang,Yong, Huang,Ming Qing, Shi,Jia Jie, Zou,Liang, Lu,Jin Jian. Bioactive platycodins from Platycodonis Radix: Phytochemistry, pharmacological activities, toxicology and pharmacokinetics[J]. Food Chemistry, 2020, 327, 127029.
Authors:  Zhang,Le Le;  Huang,Mu Yang;  Yang,Yong;  Huang,Ming Qing;  Shi,Jia Jie; et al.
Favorite | TC[WOS]:64 TC[Scopus]:68  IF:8.5/8.2 | Submit date：2021/03/02
Pharmacokinetics  Pharmacological Activities  Phytochemistry  Platycodins  Platycodonis Radix  Toxicology  
Activation of notch 3/c-MYC/CHOP axis regulates apoptosis and promotes sensitivity of lung cancer cells to mTOR inhibitor everolimus Journal article
Li,Ting, Xu,Xiao Huang, Guo,Xia, Yuan,Tao, Tang,Zheng Hai, Jiang,Xiao Ming, Xu,Yu Lian, Zhang,Le Le, Chen,Xiuping, Zhu,Hong, Shi,Jia Jie, Lu,Jin Jian. Activation of notch 3/c-MYC/CHOP axis regulates apoptosis and promotes sensitivity of lung cancer cells to mTOR inhibitor everolimus[J]. Biochemical Pharmacology, 2020, 175.
Authors:  Li,Ting;  Xu,Xiao Huang;  Guo,Xia;  Yuan,Tao;  Tang,Zheng Hai; et al.
Favorite | TC[WOS]:17 TC[Scopus]:19  IF:5.3/5.2 | Submit date：2021/03/01
Lung Cancer  Notch 3  C-myc  Chop  Apoptosis  
Investigational hypoxia-activated prodrugs: Making sense of future development Journal article
Min Xia Su, Le Le Zhang, Zhang Jian Huang, Jia Jie Shi, Jin Jian Lu. Investigational hypoxia-activated prodrugs: Making sense of future development[J]. CURRENT DRUG TARGETS, 2019, 20(6), 668-678.
Authors:  Min Xia Su;  Le Le Zhang;  Zhang Jian Huang;  Jia Jie Shi;  Jin Jian Lu
Favorite | TC[WOS]:9 TC[Scopus]:11  IF:3.0/3.3 | Submit date：2021/03/02
Dna Alkylating Agents  Hypoxia-activated Prodrug  Patient Selection  Reductase Activity  Targeted Drugs  Topoisomerase Ii Inhibitors  
DJ-1 mediates the resistance of cancer cells to dihydroartemisinin through reactive oxygen species removal Journal article
Hong Zhu, Si-Da Liao, Jia-Jie Shi, Lin-Lin Chang, Yun-Guang Tong, Ji Cao, Ying-Ying Fu, Xiu-Ping Chen, Mei-Dan Ying, Bo Yang, Qiao-Jun He, Jin-Jian Lu. DJ-1 mediates the resistance of cancer cells to dihydroartemisinin through reactive oxygen species removal[J]. Free Radical Biology and Medicine, 2014, 71, 121-132.
Authors:  Hong Zhu;  Si-Da Liao;  Jia-Jie Shi;  Lin-Lin Chang;  Yun-Guang Tong; et al.
Favorite | TC[WOS]:34 TC[Scopus]:35 | Submit date：2018/12/28
Dihydroartemisinin  Dj-1  Free Radicals  Mitochondria  Proteomic  Resistant  
Dihydroartemisinin-induced inhibition of proliferation in BEL-7402 cells: An analysis of the mitochondrial proteome Journal article
Jin-Jian Lu, Zhen Yang, De-Zhao Lu, Xing-De Wo, Jia‑Jie Shi, Tao‑Qi Lin, Mi-Mi Wang, Yi Li, Li-Hua Tang. Dihydroartemisinin-induced inhibition of proliferation in BEL-7402 cells: An analysis of the mitochondrial proteome[J]. Molecular Medicine Reports, 2012, 6(2), 429-433.
Authors:  Jin-Jian Lu;  Zhen Yang;  De-Zhao Lu;  Xing-De Wo;  Jia‑Jie Shi; et al.
Favorite | TC[WOS]:10 TC[Scopus]:14 | Submit date：2018/12/28
Dihydroartemisinin  Energy Metabolism  Hepatocarcinoma  Mitochondria  Proteomics